Cerus EBITDA Margin 2010-2023 | CERS
Cerus EBITDA Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
2023-12-31 | $0.19B | $-0.03B | -15.05% |
2023-09-30 | $0.18B | $-0.04B | -21.20% |
2023-06-30 | $0.18B | $-0.04B | -22.40% |
2023-03-31 | $0.18B | $-0.04B | -19.67% |
2022-12-31 | $0.19B | $-0.03B | -16.49% |
2022-09-30 | $0.19B | $-0.03B | -14.97% |
2022-06-30 | $0.18B | $-0.03B | -16.94% |
2022-03-31 | $0.17B | $-0.04B | -22.54% |
2021-12-31 | $0.16B | $-0.05B | -28.75% |
2021-09-30 | $0.14B | $-0.05B | -37.50% |
2021-06-30 | $0.13B | $-0.06B | -43.51% |
2021-03-31 | $0.12B | $-0.06B | -47.50% |
2020-12-31 | $0.12B | $-0.06B | -48.70% |
2020-09-30 | $0.11B | $-0.06B | -54.21% |
2020-06-30 | $0.10B | $-0.06B | -60.40% |
2020-03-31 | $0.10B | $-0.06B | -65.63% |
2019-12-31 | $0.09B | $-0.06B | -68.82% |
2019-09-30 | $0.09B | $-0.06B | -72.41% |
2019-06-30 | $0.08B | $-0.06B | -72.29% |
2019-03-31 | $0.08B | $-0.06B | -70.00% |
2018-12-31 | $0.08B | $-0.05B | -70.67% |
2018-09-30 | $0.07B | $-0.05B | -64.86% |
2018-06-30 | $0.07B | $-0.05B | -69.12% |
2018-03-31 | $0.06B | $-0.05B | -85.00% |
2017-12-31 | $0.05B | $-0.06B | -109.80% |
2017-09-30 | $0.04B | $-0.06B | -138.64% |
2017-06-30 | $0.04B | $-0.06B | -153.66% |
2017-03-31 | $0.04B | $-0.06B | -161.54% |
2016-12-31 | $0.04B | $-0.06B | -153.85% |
2016-09-30 | $0.04B | $-0.06B | -162.16% |
2016-06-30 | $0.04B | $-0.06B | -177.14% |
2016-03-31 | $0.04B | $-0.06B | -174.29% |
2015-12-31 | $0.04B | $-0.06B | -171.43% |
2015-09-30 | $0.04B | $-0.06B | -165.71% |
2015-06-30 | $0.04B | $-0.05B | -143.24% |
2015-03-31 | $0.04B | $-0.05B | -132.43% |
2014-12-31 | $0.04B | $-0.04B | -118.92% |
2014-09-30 | $0.04B | $-0.04B | -105.56% |
2014-06-30 | $0.04B | $-0.04B | -94.59% |
2014-03-31 | $0.04B | $-0.03B | -81.58% |
2013-12-31 | $0.04B | $-0.03B | -67.50% |
2013-09-30 | $0.04B | $-0.02B | -54.76% |
2013-06-30 | $0.04B | $-0.02B | -48.72% |
2013-03-31 | $0.04B | $-0.02B | -44.74% |
2012-12-31 | $0.04B | $-0.02B | -43.24% |
2012-09-30 | $0.04B | $-0.02B | -44.44% |
2012-06-30 | $0.04B | $-0.02B | -40.54% |
2012-03-31 | $0.04B | $-0.02B | -42.86% |
2011-12-31 | $0.03B | $-0.02B | -45.45% |
2011-09-30 | $0.03B | $-0.02B | -55.17% |
2011-06-30 | $0.03B | $-0.02B | -64.00% |
2011-03-31 | $0.02B | $-0.01B | -58.33% |
2010-12-31 | $0.02B | $-0.01B | -60.87% |
2010-09-30 | $0.02B | $-0.02B | -68.18% |
2010-06-30 | $0.02B | $-0.02B | -81.82% |
2010-03-31 | $0.02B | $-0.02B | -100.00% |
2009-12-31 | $0.02B | $-0.02B | -135.29% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.305B | $0.156B |
Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $186.151B | 24.44 |
Stryker (SYK) | United States | $123.816B | 30.70 |
Medtronic (MDT) | Ireland | $105.535B | 14.94 |
Boston Scientific (BSX) | United States | $98.780B | 32.84 |
EssilorLuxottica (ESLOY) | France | $98.612B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $41.070B | 0.00 |
Haleon (HLN) | United Kingdom | $37.534B | 29.36 |
ResMed (RMD) | United States | $26.307B | 26.30 |
Zimmer Biomet Holdings (ZBH) | United States | $24.538B | 15.80 |
Terumo (TRUMY) | Japan | $24.492B | 34.59 |
Baxter (BAX) | United States | $20.044B | 14.62 |
Koninklijke Philips (PHG) | Netherlands | $18.554B | 14.80 |
Insulet (PODD) | United States | $11.641B | 61.12 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.422B | 0.00 |
Demant (WILYY) | Denmark | $9.965B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.977B | 23.77 |
BellRing Brands (BRBR) | United States | $7.070B | 38.01 |
Lantheus Holdings (LNTH) | United States | $4.374B | 11.29 |
Perrigo (PRGO) | Ireland | $4.174B | 11.94 |
Haemonetics (HAE) | United States | $4.126B | 21.10 |
GN Store Nord (GNNDY) | Denmark | $3.707B | 24.00 |
Prestige Consumer Healthcare (PBH) | United States | $3.459B | 16.35 |
Envista Holdings (NVST) | United States | $3.430B | 13.05 |
QuidelOrtho (QDEL) | United States | $2.616B | 9.50 |
Green Thumb Industries (GTBIF) | United States | $2.602B | 82.47 |
Neogen (NEOG) | United States | $2.515B | 24.19 |
ICU Medical (ICUI) | United States | $2.333B | 17.41 |
TG Therapeutics (TGTX) | United States | $2.130B | 689.00 |
Owens & Minor (OMI) | United States | $1.899B | 18.23 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.835B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.710B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $1.659B | 0.00 |
National Vision Holdings (EYE) | United States | $1.471B | 45.81 |
InMode (INMD) | Israel | $1.462B | 7.57 |
LeMaitre Vascular (LMAT) | United States | $1.420B | 46.86 |
AdaptHealth (AHCO) | United States | $1.241B | 9.34 |
Warby Parker (WRBY) | United States | $1.185B | 0.00 |
AtriCure (ATRC) | United States | $1.122B | 0.00 |
MacroGenics (MGNX) | United States | $0.977B | 0.00 |
Canopy Growth (CGC) | Canada | $0.723B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.718B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.691B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.690B | 14.90 |
Evolus (EOLS) | United States | $0.668B | 0.00 |
Quanterix (QTRX) | United States | $0.605B | 0.00 |
Jin Medical (ZJYL) | China | $0.600B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.539B | 11.67 |
Valneva SE (VALN) | France | $0.528B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.481B | 0.00 |
PetIQ (PETQ) | United States | $0.479B | 17.89 |
ZimVie (ZIMV) | United States | $0.420B | 25.72 |
Biote (BTMD) | United States | $0.413B | 3.93 |
OraSure Technologies (OSUR) | United States | $0.404B | 6.68 |
Surmodics (SRDX) | United States | $0.377B | 40.75 |
Zynex (ZYXI) | United States | $0.366B | 42.15 |
Aurora Cannabis (ACB) | Canada | $0.352B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.305B | 30.31 |
Sanara MedTech (SMTI) | United States | $0.291B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.254B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.246B | 15.01 |
Organigram Holdings (OGI) | Canada | $0.195B | 0.00 |
Veru (VERU) | United States | $0.192B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.180B | 0.00 |
High Tide (HITI) | Canada | $0.179B | 0.00 |
Omeros (OMER) | United States | $0.177B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.158B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.147B | 0.00 |
FitLife Brands (FTLF) | United States | $0.133B | 21.39 |
Eagleford Energy (GRUSF) | United States | $0.126B | 63.55 |
Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
InterCure (INCR) | Israel | $0.115B | 19.46 |
Fonar (FONR) | United States | $0.106B | 9.14 |
MariMed (MRMD) | United States | $0.101B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.095B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
Safety Shot (SHOT) | United States | $0.091B | 0.00 |
Brainsway (BWAY) | Israel | $0.081B | 0.00 |
Chimerix (CMRX) | United States | $0.079B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.071B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
United Health Products (UEEC) | United States | $0.050B | 0.00 |
Apyx Medical (APYX) | United States | $0.046B | 0.00 |
Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
Bright Green (BGXX) | United States | $0.040B | 0.00 |
ImmuCell (ICCC) | United States | $0.039B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 14.30 |
Modular Medical (MODD) | United States | $0.036B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
GlucoTrack (GCTK) | United States | $0.022B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 72.64 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |